From: Values and DSM-5: looking at the debate on attenuated psychosis syndrome
 |  | Researchers in high-risk mental states | Psychotic Disorders Work Group | Patient advocacy groups (NAMI) | External stakeholders (Allen Frances) | DSM-5 |
---|---|---|---|---|---|---|
Value-commitments | Â | Â | Â | Â | Â | Â |
Aiding the ill by relieving suffering and preventing psychosis | [ethical] | +++ | +++ | +++ | + | + |
Scientific development by research expansion and knowledge acquisition | [epistemic/pragmatic] | ++ | ++ | - | - | + |
Value-consequences | Â | Â | Â | Â | Â | Â |
Stigmatization and inappropriate prescription of antipsychotic medication | [ethical] | ++(+) | ++ | +++ | +++ | - |
Value-entailments | Â | Â | Â | Â | Â | Â |
Mental health commercialism and the influence of political and economic forces | [ontological/pragmatic] | (++) | - | ++ | +++ | - |
Neurobiological reductionism and reification | [ontological] | (++) | - | - | - | - |